MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, VYNE made $9,575K in revenue. -$5,757K in net income. Net profit margin of -60.13%.

Income Overview

Revenue
$9,575K
Net Income
-$5,757K
Net Profit Margin
-60.13%
EPS
-$0.13
Unit: Thousand (K) dollars
Revenue Breakdown
    • Research and development
    • General and administrative
    • Other income, net
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-06-30
2025-03-31
2024-12-31
2024-09-30
Total revenues
69 ---
Total revenues
100 202 91 121
Research and development
4,881 6,124 6,696 10,248
General and administrative
2,730 3,275 3,470 2,964
Total operating expenses
7,611 9,399 10,166 13,212
Operating loss
-7,542 -9,197 -10,075 -13,091
Other income, net
1,795 594 950 934
Loss from continuing operations before income taxes
-5,747 -8,603 -9,125 -12,157
Income tax expense
0 -1 -
Loss from continuing operations
-5,747 -8,603 -9,127 -12,157
Loss from discontinued operations, net of income taxes
-8 -8 -5 -
Net loss
-5,755 -8,611 -9,135 -12,157
Unrealized (losses) gains on marketable securities, net of tax of 0
-2 -20 -55 92
Total other comprehensive (loss) gain
-2 -20 -55 92
Comprehensive loss
-5,757 -8,631 -9,190 -12,065
Loss per share, basic (in dollars per share)
-0.13 -0.2 -0.21 -0.29
Loss per share, diluted (in dollars per share)
-0.13 -0.2 -0.21 -0.29
Weighted average shares outstanding - basic (in shares)
42,759,000 42,673,000 -21,292,000 42,587,000
Weighted average shares outstanding - diluted (in shares)
42,759,000 42,673,000 -21,292,000 42,587,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$5,757K Total othercomprehensive (loss) gain-$2K Net loss-$5,755K Unrealized (losses) gainson marketable...-$2K Loss fromdiscontinued operations, net...-$8K Loss from continuingoperations-$5,747K Loss from continuingoperations before income...-$5,747K Other income, net$1,795K Operating loss-$7,542K Total revenues$100K Total operatingexpenses$7,611K General andadministrative$2,730K Research and development$4,881K

VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Inc. (VYNE)